Denali Therapeutics Inc. (DNLI) — SC 13G/A Filings
All SC 13G/A filings from Denali Therapeutics Inc.. Browse 11 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (11)
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 8, 2024
- SC 13G/A Filing — Nov 8, 2024
- SC 13G/A Filing — Nov 7, 2024
- SC 13G/A Filing — Oct 21, 2024
- SC 13G/A Filing — Feb 13, 2024
- SC 13G/A Filing — Feb 13, 2024
-
Biogen Amends Denali Stake: Ownership Update Filed
— Feb 12, 2024 Risk: medium
Biogen Inc. filed an amended SC 13G/A on February 12, 2024, indicating a change in its ownership of Denali Therapeutics Inc. common stock as of December 31, 202 -
Temasek Holdings Amends Denali Therapeutics Stake Filing
— Jan 30, 2024
Temasek Holdings (Private) Ltd, a major investment company, filed an amended SC 13G/A on January 30, 2024, indicating their ownership of Denali Therapeutics Inc -
Baillie Gifford Amends Denali Therapeutics Stake (SC 13G/A)
— Jan 30, 2024
Baillie Gifford & Co, a prominent investment management firm, has filed an Amendment No. 6 to its Schedule 13G for Denali Therapeutics Inc. This filing, dated D -
BlackRock Amends Denali Therapeutics Stake, Maintains Position
— Jan 25, 2024
BlackRock Inc. filed an amended Schedule 13G/A on January 25, 2024, indicating its ownership of Denali Therapeutics Inc. common stock as of December 31, 2023. T
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX